Back

Impact of coronary artery disease phenotype on treatment in chronic coronary syndromes: the EURECA registry

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Coronary plaque phenotypes in coronary artery disease Noninvasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Riccardo Liga

University Hospital of Pisa, Pisa (Italy)

5 More presentations in this session

Presentation thumbnail
Phenotyping coronary plaque by computed tomography in premature coronary artery disease.
Doctor G. Rahoual (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Severe periodontal disease is associated with a high-risk phenotype of coronary plaques and a higher severity of coronary atherosclerosis, as assessed by Coronary Computed Tomography Angiography
Assistant Professor I. Rodean (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
Drug-interacting gene expression levels differ between atherosclerotic plaque subtypes
Ms K. Palm (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
A context-aware deep network for automated characterization of coronary artery plaque from coronary CT angiography
Professor L. Zhong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
T regulatory cells lose their protective phenotype in patients with coronary artery disease (CAD)
Ms A. Burkard (Freiburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary plaque phenotypes in coronary artery disease

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Introduction
thumbnail
Congress Presentation
Percutaneous coronary intervention and medical therapy versus medical therapy alone in chronic coronary syndrome: A hierarchical win-ratio analysis from SCAAR
thumbnail
Congress Presentation
Targeted medical treatment based on specific endotype defined by intracoronary physiology testing leads to rapid improvement of quality of life in symptomatic patients with INOCA

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources